Monitoring of intragraft pressure of rejecting organs: Increased tissue pressure can be reduced by hyaluronidase therapy

Transplantation

Volumn 70, Issue 11 SUPPL., 2000, Pages 1575-1580

  Johnsson, C ^a   Tufveson, G ^a   Hallgren R ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; HYALURONIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EDEMA; GRAFT REJECTION; HEART TRANSPLANTATION; MALE; MONITORING; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; TISSUE PRESSURE; XENOTRANSPLANTATION;

EID: 0034671088     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200012150-00007     Document Type: Article

References (32)

1. Measurement of the subcapsular pressure of allogeneic kidney transplants: A new method for postoperative transplant monitoring
2. The subcapsular hydrostatic pressure of allogenic kidney grafts: A new clinical tool method for post-operative transplant monitoring
3. Fine-needle intrarenal manometry: A new test for rejection in cyclosporin-treated recipients of kidney transplants
4. Hyaluronidase ameliorates rejection-induced edema
5. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats
6. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft: Relationship to the transplantation edema
7. Increased hyaluronan in acutely rejecting human kidney grafts
8. Non-suture organ grafting to the neck vessels in rats
9. Edema treatment during cardiac allograft rejection
10. The detection of renal allograft rejection by fine-needle intrarenal manometry
11. Differentiation between rejection and cyclosporin-A nephrotoxicity by monitoring interstitial pressure in human renal allografts
12. The use of fine-needle intrarenal manometry in the management of renal transplant patients receiving cyclosporine
13. Intrarenal manometry in the diagnosis of acute rejection superimposed on acute tubular necrosis in renal transplantation
14. Place of intrarenal pressure measurement in transplant management
15. An assessment of intrarenal hydrostatic pressure measurements in the diagnosis of acute renal allograft rejection
16. Combination fine-needle aspiration cytology and intrarenal manometry at the onset of renal dysfunction
17. Effect of administering a high dosage glucocorticoid bolus on the survival and subcapsular hydrostatic pressure of rat kidney allografts
18. The relevance of pressure changes in transplanted hearts and kidneys in immunosuppressed rats
19. Intraorgan pressure changes in rejecting kidney, liver, and heart transplants in the rat
20. Experimentally-induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney
21. Interrelationship between stimulation of prostaglandin E and hyaluronate production by poly(I)-poly(C) and interferon in synovial fibroblast culture
22. Interleukin 1 enhances synovial cell hyaluronate synthesis
23. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts
24. CD44 and its ligand hyaluronate mediate rolling under physiological flow: A novel lymphocyte-endothelial cell primary adhesion pathway
25. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44
26. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation
27. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis
28. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages
29. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages
30. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-α and is inhibited by IL-4 and IL-13
31. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model
32. Immunomodulatory functions of hyluronate in the Lew-to-F344 model of chronic cardiac allograft rejection